Inhibition of estrogen-induced elevation of cyclic 3',5'-adenosine monophosphate in rat uterus. I. By beta-adrenergic receptor-blocking drugs.
D000227:Adenine Nucleotides / Q000032:analysis* / Q000378:metabolism; D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002369:Castration; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D007545:Isoproterenol / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects / Q000378:metabolism*
D000227:Adenine Nucleotides; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D010643:Phenoxybenzamine; D004958:Estradiol; D011433:Propranolol; D000242:Cyclic AMP; D007545:Isoproterenol; D010646:Phentolamine